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Abstract
Delirium after cardiac surgery is a major problem. The exact mechanisms behind delirium are not understood.
Potential pathways of delirium include neurotransmitter interference, global cognitive disorder, and
neuroinflammation. Several predisposing and precipitating risk factors have been identified for postoperative
delirium. The development of delirium following cardiac surgery is associated with worse outcomes in the
perioperative period. Multiple interventions are being explored for the prevention and treatment of delirium.
Studies investigating the potential roles of biomarkers in delirium as well as pharmacological interventions to
reduce the incidence and duration of delirium are necessary to mitigate this negative outcome.
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Background
Delirium is a syndrome defined as an acute state of con-
fusion and inattention which may be accompanied by an
altered level of consciousness and disorganized thinking
(Cole 2004). The American Psychiatric Association’s
Diagnostic and Statistical Manual, 5th edition (DSM-V),
provides five key components of delirium (Association
AP 2013): a disturbance in attention and awareness; the
disturbance is acute and develops over a short period of
time while fluctuating during the course of the day; a
disturbance in cognition occurs; these disturbances are
not explained by another neurocognitive disorder and
do not occur during a state of reduced level of arousal
including coma; and there is evidence to suggest that the
disturbance is caused by a medical condition, substance
intoxication or withdrawal, or side effect of a medication.
Other features of delirium may include psychomotor dis-
turbances and variable emotional states. Delirium can be
categorized into three subgroups: hypoactive, hyperactive,
or mixed. The most common type of delirium is hypoac-
tive. When making the diagnosis of delirium, agitation
must not be misinterpreted as hyperactive delirium.
Given the range of symptoms and sub-types, the diag-
nosis of delirium may be difficult and under-recognized
by healthcare professionals (Boustani et al. 2010). Several
scales are available to assist in making the correct diag-
nosis. A comparison of methods in the intensive care
unit (ICU) found the confusion assessment method for
the ICU (CAM-ICU) to be the most valid and reliable
delirium assessment tool when compared with the
Nursing Delirium Screening Scale (Nu-DESC) and
Delirium Detection Score (DDS) (Luetz et al. 2010).
Using these tests is time-consuming, especially for pro-
viders not formally trained to complete the assessment.
The optimal method(s) for assessing postoperative delir-
ium following surgery has yet to reach a generalized
consensus although the CAM-ICU is the most com-
monly used method by clinicians.
Postoperative delirium has been studied in various sur-
gical patient populations. The most extensively studied
groups are patients undergoing orthopedic procedures
such as total hip arthroplasty or total knee arthroplasty
and cardiovascular surgery patients (van Meenen et al.
2014). Delirium is associated with negative hospital
outcomes including a tenfold increased risk of death, a
fivefold increased risk of nosocomial complications
(Inouye 2006), poor 1-year functional recovery, and
postoperative cognitive decline (Saczynski et al. 2012).
The long-term cognitive decline seen in some patients
after the development of delirium is similar to that of
Alzheimer’s patients (Pandharipande et al. 2013). With
reports of up to 50 % of patients over 60 years old devel-
oping postoperative delirium following cardiac surgery
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(Rudolph et al. 2009), this patient population poses a
major burden for healthcare.
This review article discusses the pathophysiology, risk
factors, and complications of postoperative delirium fol-
lowing cardiac surgery. Pharmacological interventions
which may reduce postoperative delirium and the poten-
tial role of biomarkers in this patient population are
presented. In addition, we discuss several considerations
for future studies in the field.
Review
Pathophysiology
The underlying mechanisms behind delirium are not
fully understood. Several hypotheses exist for the patho-
physiology of delirium such as neuroinflammation
(Fig. 1). The stress associated with cardiac surgery, espe-
cially when cardiopulmonary bypass (CPB) is utilized,
leads to a systemic inflammatory response. Elevated
levels of chemokines, cytokines, and other inflammatory
markers may contribute to endothelial dysfunction and
disruption of the blood brain barrier (BBB) (Rudolph et
al. 2008). When this occurs, the brain is susceptible to
neuronal injury via neuroinflammation and the activa-
tion of microglia ensues which may be a key component
to the development of delirium (Cerejeira et al. 2010).
Neurotransmitter interference may lead to delirium.
Reduced levels of plasma cholinesterase activity have a
correlation with delirium (Cerejeira et al. 2012; Trzepacz
1996), while increased levels of dopamine may also play
a part (Gaudreau & Gagnon 2005). This theory is further
supported by evidence which suggests anticholinergic
medications and dopaminergic medications instigate de-
lirium (Gaudreau & Gagnon 2005; Trzepacz & van der
Mast 2002).
Other theories focus on a more global cognitive dis-
order in which a single molecule cannot be implicated
in delirium, but rather communication in the brain as a
whole is impaired. This may include disturbances in the
prefrontal and parietal networks, or subcortical struc-
tures including the basal ganglia, reticular activating sys-
tem, thalamic nuclei, and cerebellum (Trzepacz & van
der Mast 2002).
In cardiac surgery, the exposure to CPB and the stress
endured by the patient produces significant inflamma-
tion, and the processes of neuroinflammation provide a
logical pathway. This may also hold true in various ICU
patients with a diagnosis of sepsis, severe burn injury, or
polytrauma. Yet the evidence for an imbalance of certain
neurotransmitters and delirium is supported and has
been known for years (Cerejeira et al. 2012; Trzepacz
1996). Therefore, delirium is likely multifactorial in na-
ture and components from each theory may be involved.
Biomarkers
A direction to expand our understanding of the mecha-
nisms behind delirium and to identify patients at in-
creased risk for delirium after cardiac surgery is through
targeting biomarkers. Several studies have investigated
biomarkers in heart disease, dementia, heart failure, and
various settings of delirium, mostly in critically ill pa-
tients (Wiltfang 2014; Gaggin & Januzzi 2013; van den
Boogaard et al. 2011; Khan et al. 2011). Multiple bio-
markers have associations with delirium and may offer
support when assessing risk, establishing diagnosis, and
quantifying severity of delirium (Khan et al. 2011; Mar-
cantonio et al. 2006).
A focused approach when evaluating biomarkers is ne-
cessary, and one that aims to quantify the probable com-
ponents of neuroinflammation—endothelial dysfunction,
BBB compromise, and neuronal injury—as they relate to
cardiac surgery and postoperative delirium may be a
promising direction. Previous studies have included
pro-inflammatory, anti-inflammatory, and also neuron-
specific biomarkers. A study investigating both IL-2 and
TNF-α in coronary artery bypass grafting (CABG) patients
with CPB not only found a correlation between each bio-
marker and delirium but also provided cutoff levels for in-
creased risk of 907.5 U/ml and 10.95 pg/ml, respectively
(Kazmierski et al. 2014). High levels of IL-2 were
Fig. 1 Cardiopulmonary bypass and neuroinflammation
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associated with a higher risk of delirium following cardiac
surgery in another study (Baranyi & Rothenhausler 2014).
A prospective cohort looking at pterins in postoperative
delirium found that the preoperative neopterin level
predicted delirium and postoperative neopterin and
homovanillic acid levels were associated with delirium
after cardiac surgery (Osse et al. 2012). Even with several
studies showing associations of specific biomarkers and
delirium, a review concluded that not enough evidence
existed to support the clinical use of any biomarker for
the diagnosis of delirium (Khan et al. 2011). The review
did however state that S100B, insulin-like growth factor-1
(IGF-1), and some inflammatory markers demonstrated
promising results.
The biomarker S100B has been associated with delir-
ium and acute brain dysfunction in previous studies and
is considered a validated measure of BBB disruption
(Blyth et al. 2009). BBB disruption and neuron injury via
neuroinflammation may contribute to delirium, and
therefore, S100B provides support for this theory. Ubi-
quitin C-terminal hydrolase L1 (UCHL1) is a neuron-
specific enzyme recognized in traumatic brain injury pa-
tients as a marker for direct neuron injury (Blyth et al.
2011; Brophy et al. 2011). In addition, a link between
this enzyme and neurodegeneration has been suggested
(Figueiredo-Pereira et al. 2014; Jara et al. 2013). The bio-
marker UCHL1 has yet to be investigated in delirium
and could provide a novel way to predict and screen pa-
tients at risk for delirium following cardiac surgery by
directly detecting injury to neurons. Another pathway to
consider is impaired endothelial vascular reactivity as an
association with endothelial vascular injury and brain
dysfunction has been demonstrated (Hughes et al. 2013).
Risk factors
Many risk factors are associated with postoperative delir-
ium. While some may predispose patients to delirium,
other risk factors precipitate delirium such as medica-
tions given during the perioperative period. Predisposing
risk factors are typically long-standing with the patient
and should be recognized preoperatively in order to
screen patients for increased risk. Precipitating risk
factors must be considered by clinicians when treating
any patient, especially patients already at high risk for
postoperative delirium. Each type of risk factor can be
modifiable or non-modifiable, and if possible, those that
are modifiable should be optimized in the perioperative
period.
Advanced age is a well-recognized risk factor for post-
operative delirium. Age has been shown to be an inde-
pendent risk factor in numerous studies (Chung et al.
2015; Trabold & Metterlein 2014). And with the average
age of patients undergoing open-heart surgery in the
mid-1960s (O'Neal et al. 2013), many patients automat-
ically fall into a higher risk stratification.
Patients with cognitive impairment are also at risk for
postoperative delirium. The incidence of dementia is es-
timated at 9.8 per 1000 person-years (Ruitenberg et al.
2001), and with humans living longer in a world of
steadily increasing population, the prevalence of demen-
tia will continue to rise over the foreseeable future. Im-
paired cognition may be unrecognized in some patients
as people suffering from mild cognitive impairment may
present for surgery undiagnosed as symptoms can be
subtle at this stage of the disease (Robinson et al. 2012).
Thus, these patients are at a greater risk for delirium
without healthcare workers being aware. Clinicians
should consider screening patients for cognitive impair-
ment prior to surgery and then attempt to avoid and/or
mitigate any potential precipitating risk factors in this
population.
Other preoperative conditions found to have associa-
tions with postoperative delirium include anemia,
dehydration, electrolyte abnormalities, and signs of mal-
nutrition (Trabold & Metterlein 2014). A small prospect-
ive study of hospitalized patients over the age of 70 years
found anemia and dehydration to be risk factors for delir-
ium (Joosten et al. 2006). The finding of anemia as a risk
factor was also demonstrated in patients after lumbar
spine surgery (Fineberg et al. 2013). This finding has not
been reproduced after cardiac surgery; however, whether
or not addressing these risk factors prior to surgery can
influence the outcome of delirium has yet to be eluci-
dated. Studies which investigate the incidence of delirium
after the correction of anemia, dehydration, or other con-
ditions prior to undergoing cardiac surgery should be
conducted.
Another consideration is pharmacotherapy before,
during, and after surgery. A review of medications taken
by patients in the perioperative period of cardiac surgery
identified preoperative antipsychotics as an independent
risk factor for delirium (Tse et al. 2012). Other preopera-
tive medications that may contribute to delirium include
statins, antihypertensives, anticholinergics, antidepres-
sants, benzodiazepines, and opioids which are common
home medications for patients undergoing cardiac sur-
gery (Tse et al. 2012). Intraoperative medications associ-
ated with delirium include both fentanyl and ketamine
while diazepam has inconclusive results (Tse et al. 2012).
As for postoperative medications, risperidone was shown
to reduce the incidence of delirium by almost one third
when taken by patients after cardiac surgery as a pre-
ventive strategy (Prakanrattana & Prapaitrakool 2007).
However, the large effect size in reducing delirium in pa-
tients receiving risperidone (11.1 vs. 31.7 %; RR, 0.35
(95 % CI 0.16 to 0.77); P = 0.009) has yet to be
reproduced.
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Oxygen delivery to the brain is critical for optimal
performance of the brain’s activities. Cerebral oximetry
continuously measures cerebral oxygenation in both
hemispheres of the brain and is sometimes used in car-
diac surgery as a monitor to stratify risk in patients
throughout the perioperative period (Vretzakis et al.
2014). Previous studies have found a correlation between
low preoperative cerebral oxygenation and postoperative
delirium (Schoen et al. 2011). Desaturations in cerebral
oximetry readings while on bypass are associated with
several adverse outcomes (Vohra et al. 2009), but
whether or not this may contribute to delirium is
unknown.
Outcomes
Delirium is a condition that may affect a patient for sev-
eral days or weeks. It is associated with many significant
adverse effects and poor outcomes. The progression of
dementia after suffering from an episode of delirium
may lead to a significant decline in both physical and
cognitive functioning (Morandi et al. 2014). This is also
evident in patients without an underlying dementia as
delirium is associated with declines in both condition
and functional level in older patients (Inouye 2006).
After cardiac surgery, patients diagnosed with delirium
have a higher risk for falls, increased length of stay in
the hospital, higher likelihood of discharge to a nursing
home or home with assisted care, and prolonged
inpatient physical therapy duration (Mangusan et al.
2015). Delirium after CABG surgery is also associated
with increased mortality up to 10 years postoperatively
(Gottesman et al. 2010).
The outcomes for patients developing delirium are
clearly worse than patients who do not. Whether the
poor outcomes are a direct effect of delirium or a
marker of disease severity is unclear. Either way, these
negative outcomes lead to increased costs in not only
the healthcare field but also social costs as families incur
the increased burdens of time and money to care for rel-
atives diagnosed with delirium. Strategies to reduce
healthcare costs are becoming a major focus within the
field of medicine. Interventions to effectively treat
delirium and its complications are being explored, and
strategies to reduce healthcare costs are on the rise
(Zaubler et al. 2013). The treatment of delirium is im-
portant, but discovering ways to prevent delirium is ideal
and would likely equate to the greatest decrease in
overall healthcare costs and improved outcomes.
Pharmacological interventions
The identification and correction of risk factors includ-
ing dehydration, electrolyte imbalance, and anemia are
important and should be emphasized in every patient.
And while these non-pharmacological interventions and
others such as reorientation, effective communication,
and maintenance of consistent sleep-wake cycles are
considered first-line interventions for delirium (Young
et al. 2010), the discovery of pharmacological agents
which decrease the incidence or duration of delirium
has great potential. With the current lack of understand-
ing behind the exact pathophysiology of delirium, the
present prevention and treatment strategies are inad-
equate. As previously mentioned, second-generation an-
tipsychotics were shown to decrease the incidence of
postoperative delirium when administered prophylactic-
ally (Hirota & Kishi 2013); however, only one study in
this review was specific to cardiac surgery patients
(Prakanrattana & Prapaitrakool 2007). Also, a total of six
studies were included in this meta-analysis. Other stud-
ies have suggested patients taking preoperative antipsy-
chotics are actually at a greater risk for delirium (Tse et
al. 2012). The use of antipsychotics is a potential treat-
ment option as they may alter and subsequently correct
neurotransmitter imbalances in delirious patients (Hir-
ota & Kishi 2013; Schotte et al. 1996), but the majority
of interventions for delirium after cardiac surgery aim to
optimize analgesia and sedation regimens in the ICU
and preemptively treat delirium.
Postoperative pain may contribute to the condition of
delirium (Fong et al. 2006). Pain after cardiac surgery
can be moderate to severe with incisions to the lower
extremities and sternum and also the placement of chest
tubes. With the potential for bleeding and increased risk
of kidney injury, nonsteroidal anti-inflammatory drugs
(NSAIDs) are not ideal in this patient population.
Ketamine is one option for pain postoperatively, but it
may increase the risk of delirium (Tse et al. 2012), and
the potential side effect of hallucinations should also be
considered. The usual analgesic regimen after cardiac
surgery includes an opiate. Opiates, such as morphine
and hydromorphone, have many deleterious side effects
including nausea/vomiting, ileus, bladder dysfunction,
and respiratory depression (Memis et al. 2010). Opioids
also increase the risk of postoperative delirium, espe-
cially in elderly patients (Tse et al. 2012). The use of
intravenous acetaminophen (IVA) has been shown in
multiple studies to reduce the amount of opiates con-
sumed by surgical patients (O'Neal 2013). IVA possesses
no psychoactive properties, and it has both rapid and ef-
fective analgesic properties while considered to be a safe
and well-tolerated medication (Candiotti et al. 2010).
Given the reduction in opiate consumption, reliable
analgesic properties, and safety profile, IVA may be an
alternative for patients undergoing cardiac surgery.
In addition to optimizing pain control after cardiac
surgery, choosing the most appropriate sedation regimen
is important when trying to reduce the chance for post-
operative delirium. The importance of periodically
O’Neal and Shaw Perioperative Medicine  (2016) 5:7 Page 4 of 8
weaning sedation should not be overlooked. Overly sed-
ating patients is associated with delayed extubation and
higher mortality in the ICU (Shehabi et al. 2013; Shehabi
et al. 2012). Finding the appropriate balance of sedation
and adequate analgesia should be targeted in cardiac
surgery patients.
An ideal choice for sedation in the ICU is a medica-
tion that provides both sedation and pain relief. Dexme-
detomidine is a selective α-2 receptor agonist which
provides sedation and also has an analgesic component.
Some clinicians use caution before administering this
medication given the side effect profile which includes
bradycardia, hypotension, and hypertension with loading
doses. Cardiac surgery patients have the advantage of
pacer wire implants to avoid the side effect of bradycar-
dia, and since these patients are in the ICU, hypotension
can be treated with vasopressors when appropriate. A
study comparing sedation with propofol to dexmedeto-
midine in the ICU found no difference between the two
with regard to bradycardia and hypotension; however,
dexmedetomidine was associated with an increased risk
of hypertension in patients receiving a loading dose ini-
tially (Xia et al. 2013). This undesired side effect might
be avoided by foregoing the loading dose. Given its seda-
tive and analgesic properties with limited side effects,
dexmedetomidine could be the ideal medication for car-
diac surgery patients, and multiple studies have investi-
gated the role of dexmedetomidine in reducing delirium.
A typical sedation regimen in the ICU includes benzo-
diazepines and/or propofol. The link between benzodiaz-
epines and delirium has been demonstrated (Zaal et al.
2015; Taipale et al. 2012), and therefore, many trials have
aimed to compare these agents to dexmedetomidine.
The MENDS trial was a double-blind randomized, con-
trolled trial that found the use of dexmedetomidine to
result in fewer days of delirium in medical and surgical
ICU patients when compared to lorazepam (Pandhari-
pande et al. 2007). Achieving the goal sedation level was
also superior in the dexmedetomidine group, but mor-
tality and cost did not differ when compared to the lor-
azepam group. A larger randomized, controlled trial
SEDCOM suggested that medical and surgical ICU pa-
tients sedated with dexmedetomidine spent less time on
the ventilator, experienced fewer episodes of delirium,
and developed less tachycardia and hypertension than
patients sedated with midazolam (Riker et al. 2009). Re-
searchers have used these findings in medical and surgi-
cal ICUs to study the effects of dexmedetomidine
specifically in cardiac surgery ICU patients.
A meta-analysis including 11 randomized, controlled
or cohort studies found the use of dexmedetomidine for
sedation in cardiac surgery patients’ shortened ventilator
time, reduced the incidence of postoperative arrhyth-
mias, and reduced the incidence of delirium (Lin et al.
2012). An issue with this analysis is that some of the
main studies included in the analysis had poor designs
and variable methods to assess for delirium. The DEX-
COM study was a randomized, controlled trial which
showed a decreased duration of delirium (5 vs. 2 days,
(95 % CI 1.09 to 6.67); P = 0.0317) in patients sedated
with dexmedetomidine versus morphine (Shehabi et al.
2009). The study found no difference in incidence of de-
lirium, although the baseline delirium rate was only
15 %. Propofol was used in both study groups, and when
assessing delirium, the CAM-ICU scale was used on
both intubated and extubated patients. A prospective,
randomized, open-label trial comparing dexmedetomi-
dine to propofol to midazolam for sedation after cardiac
surgery found an incidence of only 3 % in the dexmede-
tomidine group versus 50 % in both the propofol and
midazolam groups (Maldonado et al. 2009). The large
reduction in incidence of delirium is unprecedented as
no other study has shown such a drastic reduction. A
retrospective cohort consisting of data collected from
250 hospitals found that patients receiving dexmedeto-
midine/propofol/midazolam had a decreased incidence
of delirium compared to the propofol/midazolam group,
but the method for assessing delirium was not described
(Dasta et al. 2006). Also, the primary endpoint of this
study was cost, which was also reduced in the dexmede-
tomidine/propofol/midazolam group.
More recent studies continue to support the use of
dexmedetomidine after cardiac surgery for reduction of
delirium. When comparing dexmedetomidine to remi-
fentanil for sedation after cardiac surgery, a reduction in
the incidence of delirium was shown in the dexmedeto-
midine group (8.96 vs. 22.67 %; P < 0.05) (Park et al.
2014). The study found no differences between the two
groups with respect to length of stay in the ICU, time to
extubation, hospital length of stay, and other postopera-
tive complications. Another recent single-blinded, pro-
spective randomized trial found that when compared to
propofol, the use of dexmedetomidine for sedation after
cardiac surgery resulted in reduced incidence (odds ratio
(OR) 0.46 (95 % CI 0.23 to 0.92); P = 0.028), delayed on-
set, and also shorter duration of delirium (Djaiani et al.
2015). A retrospective cohort investigating outcomes
after CABG found a decreased mortality in patients re-
ceiving dexmedetomidine perioperatively (Ji et al. 2014).
A reduction in the risk of delirium in patients receiving
dexmedetomidine (adjusted OR, 0.431 (95 % CI 0.265 to
0.701); P = 0.0007) was also reported when compared to
patients who did not receive dexmedetomidine. A larger
retrospective study including CABG and CABG plus
valve surgery patients also found a reduction in delir-
ium (5.46 vs. 7.42 %; adjusted OR, 0.53 (95 % CI 0.37
to 0.75); P = 0.003) and decreased 1-year mortality
(3.17 vs. 7.95 %; adjusted OR, 0.47 (95 % CI 0.312 to
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0.701); P = 0.0002) in patients receiving dexmedetomi-
dine (Ji et al. 2013).
Other interventions are also being studied. The use of
high-dose dexamethasone (1 mg/kg) in cardiac surgery
patients failed to show a difference in the incidence or
duration of delirium (Sauer et al. 2014). The theory that
the inflammatory response from surgery and cardiopul-
monary bypass contributes to delirium drove the
hypothesis of this study. The use of intraoperative
Bispectral Index (BIS)-guided and end-tidal anesthetic
concentration-guided depth of anesthesia protocols is an-
other direction investigators have taken (Whitlock et al.
2014). No difference was shown with either of these moni-
tors; however, low average volatile anesthetic dose was
found to be a predictor of delirium. This may be reflective
of patients with poorer health and could potentially assist
with screening for patients at higher risk for delirium.
A systematic review and meta-analysis supported the
use of dexmedetomidine, antipsychotics, and multicom-
ponent interventions for strategies to reduce postopera-
tive delirium based on the review of 38 randomized
controlled trials but did state that one of the greatest
obstacles in evaluating delirium studies is the lack of
continuity in evaluation of delirium (Zhang et al. 2013).
This is a major issue when clinicians are trying to ex-
trapolate these findings and utilize them in clinical prac-
tice. When the majority of the randomized clinical trials
on postoperative delirium show vast inconsistencies in
the method chosen to evaluate delirium, the evidence
may seem insufficient and unreliable by intensivists. And
even though evidence suggests benefits of using certain
interventions to reduce postoperative delirium after car-
diac surgery, more studies are necessary which aim to
universalize the assessment of delirium.
Future studies
Studies on this topic are not lacking in quantity but
more so in quality. Establishing a reliable, convenient,
and consistent method for diagnosing delirium is a must
for researchers in this field. More recent studies utilize
multiple assessment tools, but until a universal screening
method for delirium is accepted, it will be difficult for
studies to change clinical practice with their results.
Projects involving biomarkers and their role in delir-
ium after cardiac surgery are limitless. Aiming to target
biomarkers shown to have a correlation with delirium in
non-cardiac surgery patients should be investigated in
cardiac surgery. Biomarkers linked to the mechanisms of
delirium should also be characterized potentially through
targeting biomarkers of the neuroinflammatory pathway
of endothelial dysfunction, BBB disruption, and neuronal
injury. This may lead to identifying patients at higher risk,
preemptively treating those patients, and further defining
the severity of disease in patients with delirium. Finding
ways to effectively treat cerebral oxygen desaturations dur-
ing CPB may also reduce postoperative delirium.
Modifications to medications administered before, dur-
ing, and after surgery should continue to be investigated.
The avoidance of medications such as benzodiazepines
and opiates by using other sedatives and analgesics has
proven to decrease delirium. Considering the flaws in
studies using dexmedetomidine in the ICU, more research
is necessary with this medication to determine the optimal
dosing and timing of its use and solidify the evidence that
it decreases delirium after cardiac surgery. The use of IVA
may limit opiate consumption and play a role in decreas-
ing delirium in these patients. An ongoing trial investigat-
ing the effects of both dexmedetomidine and IVA on
delirium following cardiac surgery may provide sufficient
evidence to support the use of these medications in the
prevention of postoperative delirium (NCT02546765).
Other analgesics such as gabapentin and pregabalin
given preoperatively should also be considered.
Conclusions
Delirium is an ongoing issue in cardiac surgery patients.
Many risk factors are known, and some can be modified
perioperatively. The complications associated with post-
operative delirium lead to increased morbidity and
mortality as well as higher healthcare costs. Several in-
terventions in the ICU after cardiac surgery have been
investigated, but the results have yet to significantly
change clinical practice. The role of biomarkers in post-
operative delirium after cardiac surgery is promising but
not yet fully elucidated. More research and randomized
clinical trials in this field is both warranted and neces-
sary given the negative outcomes associated with
delirium.
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